[1]
2024. Terapêutica farmacológica com SGLT2i no controlo da diabetes mellitus tipo 2 e na obesidade associada. Portuguese Journal of Family Medicine and General Practice. 40, 2 (Apr. 2024), 148–56. DOI:https://doi.org/10.32385/rpmgf.v40i2.13647.